• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

NeurogesX Inc

+ Add to Watchlist

NGSX:US

0.0048 USD 0.0022 31.43%

As of 20:10:00 ET on 08/27/2014.

Snapshot for NeurogesX Inc (NGSX)

Open: 0.0060 Day's Range: 0.0048 - 0.0060 Volume: 79,940
Previous Close: 0.0070 52wk Range: 0.0025 - 0.0180 1-Yr Rtn: -49.47%

Stock Chart for NGSX

No chart data available.
  • NGSX:US 0.0048
  • 1D
  • 1M
  • 1Y
0.0070
Interactive NGSX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for NGSX

Current P/E Ratio (ttm) -
Estimated P/E(12/2012) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.9200
Est. EPS (USD) (12/2012) -
Est. PEG Ratio -
Market Cap (M USD) 0.16
Shares Outstanding (M) 33.33
30 Day Average Volume 15,439
Price/Book (mrq) -
Price/Sale (ttm) 0.0129
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for NGSX

No data available

Company Profile & Key Executives for NGSX

NeurogesX, Inc. is a biopharmaceutical company. The Company develops treatments for chronic peripheral neuropathic pain including postherpetic neuralgia, painful HIV-distal sensory polyneuropathy, and painful diabetic neuropathy.

Stephen F GhiglieriExec VP/CFO/COO/SecretaryStephen J PeroutkaExec VP/Chief Medical Officer
Michael E MarkelsSenior VP:CommercialSara PellegrinoInvestor Relations
More Company Profile & Key Executives for NGSX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil